MetLife Investment Management’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $565K | Buy |
19,678
+799
| +4% | +$22.2K | ﹤0.01% | 1845 |
|
|
2026
Q1 | $353K | Sell |
18,879
-10,948
| -37% | -$209K | ﹤0.01% | 1921 |
|
|
2025
Q4 | $689K | Hold |
29,827
| – | – | ﹤0.01% | 1641 |
|
|
2025
Q3 | $801K | Hold |
29,827
| – | – | ﹤0.01% | 1580 |
|
|
2025
Q2 | $500K | Sell |
29,827
-281
| -0.9% | -$4.95K | ﹤0.01% | 1673 |
|
|
2025
Q1 | $531K | Sell |
30,108
-288
| -0.9% | -$5.78K | ﹤0.01% | 1700 |
|
|
2024
Q4 | $738K | Buy |
30,396
+1,796
| +6% | +$51.3K | ﹤0.01% | 1578 |
|
|
2024
Q3 | $1.06M | Hold |
28,600
| – | – | 0.01% | 1361 |
|
|
2024
Q2 | $1.36M | Buy |
28,600
+2,800
| +11% | +$123K | 0.01% | 1177 |
|
|
2024
Q1 | $988K | Hold |
25,800
| – | – | 0.01% | 1307 |
|
|
2023
Q4 | $805K | Hold |
25,800
| – | – | 0.01% | 1424 |
|
|
2023
Q3 | $1.04M | Sell |
25,800
-28,007
| -52% | -$1.31M | 0.01% | 1211 |
|
|
2023
Q2 | $2.83M | Sell |
53,807
-242
| -0.4% | -$14.7K | 0.02% | 776 |
|
|
2023
Q1 | $3.46M | Sell |
54,049
-583
| -1% | -$38K | 0.02% | 665 |
|
|
2022
Q4 | $2.65M | Sell |
54,632
-509
| -0.9% | -$31.9K | 0.02% | 777 |
|
|
2022
Q3 | $3.89M | Sell |
55,141
-222
| -0.4% | -$19K | 0.03% | 536 |
|
|
2022
Q2 | $3.93M | Sell |
55,363
-326
| -0.6% | -$21K | 0.03% | 570 |
|
|
2022
Q1 | $4.45M | Buy |
55,689
+16,152
| +41% | +$1.2M | 0.03% | 612 |
|
|
2021
Q4 | $3.61M | Buy |
39,537
+297
| +0.8% | +$31.9K | 0.03% | 571 |
|
|
2021
Q3 | $5.04M | Sell |
39,240
-1,232
| -3% | -$172K | 0.05% | 362 |
|
|
2021
Q2 | $6.17M | Sell |
40,472
-621
| -2% | -$81.8K | 0.05% | 300 |
|
|
2021
Q1 | $4.33M | Buy |
41,093
+21,674
| +112% | +$2.17M | 0.04% | 467 |
|
|
2020
Q4 | $1.54M | Hold |
19,419
| – | – | 0.01% | 941 |
|
|
2020
Q3 | $1.1M | Hold |
19,419
| – | – | 0.01% | 984 |
|
|
2020
Q2 | $1.2M | Hold |
19,419
| – | – | 0.01% | 957 |
|
|
2020
Q1 | $626K | Hold |
19,419
| – | – | 0.01% | 1097 |
|
|
2019
Q4 | $683K | Hold |
19,419
| – | – | 0.01% | 1287 |
|
|
2019
Q3 | $501K | Hold |
19,419
| – | – | 0.01% | 1422 |
|
|
2019
Q2 | $571K | Sell |
19,419
-38,838
| -67% | -$1.12M | 0.01% | 1399 |
|
|
2019
Q1 | $1.99M | Buy |
58,257
+38,838
| +200% | +$1.37M | 0.01% | 1270 |
|
|
2018
Q4 | $620K | Hold |
19,419
| – | – | 0.01% | 1235 |
|
|
2018
Q3 | $932K | Hold |
19,419
| – | – | 0.01% | 1163 |
|
|
2018
Q2 | $602K | Hold |
19,419
| – | – | 0.01% | 1300 |
|
|
2018
Q1 | $287K | Hold |
19,419
| – | – | ﹤0.01% | 1698 |
|
|
2017
Q4 | $301K | Buy |
+19,419
| New | +$289K | ﹤0.01% | 1709 |
|
Other funds holding STAA
BC
MAP
YC
AIM
MetLife Investment Management's STAA Position: Q2 2026 in Review
MetLife Investment Management increased its STAAR Surgical (STAA) stake by 4.2% in Q2 2026, buying an estimated $22.2K and bringing the position to 19,678 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #1845.
MetLife Investment Management first reported a position in STAA in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.17M in Q2 2021. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.
- MetLife Investment Management held 19,678 shares of STAAR Surgical worth $565K as of Q2 2026.
- MetLife Investment Management bought 799 STAAR Surgical shares in Q2 2026, an estimated $22.2K.
- STAAR Surgical made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1845 holding.
- MetLife Investment Management first reported a position in STAAR Surgical in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's STAAR Surgical position peaked at $6.17M in Q2 2021.
- 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.